Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 2
2020 2
2021 7
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, Okunade AL, Patterson BW, Nyangau E, Field T, Sirlin CB, Talukdar S, Hellerstein MK, Klein S. Smith GI, et al. Among authors: nyangau e. J Clin Invest. 2020 Mar 2;130(3):1453-1460. doi: 10.1172/JCI134165. J Clin Invest. 2020. PMID: 31805015 Free PMC article. Clinical Trial.
Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
Cohen CC, Li KW, Alazraki AL, Beysen C, Carrier CA, Cleeton RL, Dandan M, Figueroa J, Knight-Scott J, Knott CJ, Newton KP, Nyangau EM, Sirlin CB, Ugalde-Nicalo PA, Welsh JA, Hellerstein MK, Schwimmer JB, Vos MB. Cohen CC, et al. Among authors: nyangau em. J Clin Invest. 2021 Dec 15;131(24):e150996. doi: 10.1172/JCI150996. J Clin Invest. 2021. PMID: 34907907 Free PMC article. Clinical Trial.
Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer.
Cheng E, Caan BJ, Cawthon PM, Evans WJ, Hellerstein MK, Shankaran M, Nyangau E, Campbell KL, Lee C, Binder AM, Meyerhardt JA, Schmitz KH, Cespedes Feliciano EM. Cheng E, et al. Among authors: nyangau e. Cancer Epidemiol Biomarkers Prev. 2023 Oct 2;32(10):1373-1381. doi: 10.1158/1055-9965.EPI-23-0227. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37450841 Free PMC article.
Comparison of Bioelectrical Impedance Indices for Skeletal Muscle Mass and Intracellular Water Measurements of Physically Active Young Men and Athletes.
Sagayama H, Kondo E, Tanabe Y, Uchizawa A, Evans WJ, Shankaran M, Nyangau E, Hellerstein M, Shiose K, Yoshida T, Yasukata J, Higaki Y, Ohnishi T, Takahashi H, Yamada Y. Sagayama H, et al. Among authors: nyangau e. J Nutr. 2023 Sep;153(9):2543-2551. doi: 10.1016/j.tjnut.2023.07.010. Epub 2023 Jul 24. J Nutr. 2023. PMID: 37495114
The D3 -creatine dilution method non-invasively measures muscle mass in mice.
Wimer L, Goncharova E, Galkina S, Nyangau E, Shankaran M, Davis A, Prado L, Munoz MC, Epstein S, Patterson C, Shaum N, Hellerstein M, Evans W, Melov S. Wimer L, et al. Among authors: nyangau e. Aging Cell. 2023 Aug;22(8):e13897. doi: 10.1111/acel.13897. Epub 2023 Jun 5. Aging Cell. 2023. PMID: 37272263 Free PMC article.
Estimation of skeletal muscle mass in 4-year-old children using the D3-creatine dilution method.
Sidiqi A, Fariha F, Shanta SS, Dasiewicz A, Mahmud AA, Moore DR, Shankaran M, Hellerstein MK, Evans WJ, Gernand AD, Islam MM, Abrams SA, Harrington J, Nyangau E, Roth DE, O'Callaghan KM. Sidiqi A, et al. Among authors: nyangau e. Pediatr Res. 2023 Sep;94(3):1195-1202. doi: 10.1038/s41390-023-02587-1. Epub 2023 Apr 10. Pediatr Res. 2023. PMID: 37037953 Free PMC article.
20 results